Myelofibrosis (MF) is an uncommon type of chronic leukemia which disrupts the body's normal production of blood cells and causes scarring of bone marrow, anemia, fatigue, and an enlarged spleen. Here the blood stem cells develop a genetic mutation having a serious effect on blood production. The treatment goal for most patients with MF is to relieve symptoms, reduce an enlarged spleen, improve blood cell counts and reduce complications. Novartis has organized an interactive webinar Live from Delhi on 18th May 2019, 07:30 pm onwards.
Prof. Giuseppe A Palumbo will discuss “How I Treat MyeloFibrosis (MF) In 2019: Current goal in therapy and symptoms-based approach to management.” We invite you to submit your questions which will be answered by the speaker at the end of the session. Disclaimer : For the use of Registered Medical Practitioners only. WEBINAR/JAKAVI/ONCO/1172728/14/MAY/2019
